Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $44.5B | +$1.5B | 95 | 1.58% | Increased |
|
| 2 |
BlackRock
New York
| $43.3B | +$4.54B | 104 | 1.73% | Increased |
|
| 3 |
Fidelity Investments
Boston,
Massachusetts
| $26.6B | +$3.29B | 69 | 2.93% | Increased |
|
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
| $22.2B | -$1.03B | 55 | 2.79% | Reduced |
|
| 5 |
State Street
Boston,
Massachusetts
| $21.7B | +$1B | 89 | 1.58% | Increased |
|
| 6 |
Wellington Management Group
Boston,
Massachusetts
| $14.5B | +$1.54B | 36 | 3.23% | Increased |
|
| 7 |
Capital World Investors
Los Angeles,
California
| $13.1B | +$398M | 21 | 3.17% | Increased |
|
| 8 |
Massachusetts Financial Services
Boston,
Massachusetts
| $10.1B | -$140M | 19 | 4% | Reduced |
|
| 9 |
Capital Research Global Investors
Los Angeles,
California
| $9.64B | +$296M | 10 | 3.05% | Increased |
|
| 10 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $9.08B | -$247M | 12 | 6.92% | Reduced |
|
| 11 |
Morgan Stanley
New York
| $8.75B | +$123M | 111 | 1.94% | Increased |
|
| 12 |
Geode Capital Management
Boston,
Massachusetts
| $7.75B | +$240M | 106 | 1.66% | Increased |
|
| 13 |
Bank of America
Charlotte,
North Carolina
| $7.7B | +$312M | 103 | 1.17% | Increased |
|
| 14 |
Northern Trust
Chicago,
Illinois
| $6.52B | +$279M | 96 | 1.54% | Increased |
|
| 15 |
Norges Bank
Oslo,
Norway
| $5.9B | +$247M | 44 | 1.7% | Increased |
|
| 16 |
JP Morgan Chase
New York
| $5.78B | +$587M | 100 | 1.11% | Increased |
|
| 17 |
Janus Henderson Group
London,
| $5.58B | +$247M | 24 | 3.13% | Increased |
|
| 18 |
Bank of New York Mellon
New York
| $5.46B | +$413M | 87 | 1.46% | Increased |
|
| 19 |
Primecap Management
Pasadena,
California
| $5.27B | -$218M | 13 | 4.52% | Reduced |
|
| 20 |
Invesco
Atlanta,
Georgia
| $4.64B | +$241M | 49 | 1.66% | Increased |
|
| 21 |
Nuveen
Charlotte,
North Carolina
| $4.21B | +$329M | 77 | 1.71% | Increased |
|
| 22 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $4.18B | +$203M | 11 | 6.72% | Increased |
|
| 23 |
Capital International Investors
Los Angeles,
California
| $4.06B | +$49.3M | 17 | 1.33% | Increased |
|
| 24 |
Franklin Resources
San Mateo,
California
| $3.99B | +$194M | 30 | 2.06% | Increased |
|
| 25 |
Goldman Sachs
New York
| $3.71B | -$90.8M | 87 | 1.13% | Reduced |
|